111 Three key chemokines (CCL2, CXCL10 AND IL8) involved in benign prostatic hyperplasia inflammation are reduced by Permixon® treatment
| Autor: | Latil, A., Rouquet, J., Issac, C., Lantoine-Adam, F, Libon, C., Nguyen, T. |
|---|---|
| Zdroj: | In European Urology Supplements February 2012 11(1):e111-e111 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect